Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients

Ann Surg. 2010 Apr;251(4):601-3. doi: 10.1097/SLA.0b013e3181d6115f.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Axilla
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery*
  • Disease-Free Survival
  • Female
  • Humans
  • Lymph Node Excision*
  • Lymphatic Metastasis
  • Sentinel Lymph Node Biopsy*
  • Survival Rate